Aequus Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Aequus Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 82% to $254,896. The net income raised on -$2,964,722 and profit margin reached -1163%. Total operating expenses were $2,963,948.
Profit Margin
| 2014 | 0 | -2.41M | |
|---|---|---|---|
| 2015 | 0 | -5.01M | |
| 2016 | 701.63K | -4.81M | -685.84% |
| 2017 | 1.13M | -3.88M | -340.74% |
| 2018 | 1.41M | -2.80M | -198.81% |
| 2019 | 1.63M | -3.10M | -190.26% |
| 2020 | 2.59M | -1.04M | -40.32% |
| 2021 | 2.71M | -1.80M | -66.66% |
| 2022 | 1.37M | -3.21M | -232.65% |
| 2023 | 254.89K | -2.96M | -1163.11% |
AQS.V Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 254.89K | 1.37M | 2.71M | 2.59M | 1.63M | 1.41M | 1.13M | 701.63K | 0 | 0 |
Cost of revenue | 249.39K | 233.39K | 25.77K | 0 | 0 | 0 | 0 | 0 | 86.77K | 0 |
Gross profit | 5.49K | 1.14M | 2.68M | 2.59M | 1.63M | 1.41M | 1.13M | 701.63K | -86.77K | 0 |
Operating exp. | ||||||||||
Research and development | 301.28K | 168.71K | 296.84K | 54.60K | 210.82K | 526.93K | 894.87K | 1.12M | 2.14M | 1.04M |
Selling and marketing | 385.94K | 494.89K | 1.92M | 1.54M | 1.85M | 1.64M | 720.52K | 1.76M | 555.17K | 54.58K |
Total operating expenses | 2.96M | 3.64M | 4.05M | 3.11M | 3.85M | 4.21M | 5.05M | 5.56M | 5.05M | 2.47M |
Operating income | -2.82M | -2.49M | -1.35M | -521.57K | -2.20M | -2.80M | -3.93M | 4.86M | 5.05M | 2.47M |
Other income (expenses), net | -144.43K | -712.00K | -482 | -519.25K | -479.02K | -1.02K | 47.91K | -2.33K | 43.74K | 66.12K |
Income before tax | -2.96M | -3.21M | -1.80M | -1.04M | -3.10M | -2.80M | -3.88M | -4.86M | -5.01M | -2.41M |
Income tax expense | 0 | -1 | 454.84K | 519.59K | 418.66K | -4.28K | -30.10K | -50.72K | -43.74K | -66.12K |
Net income | -2.96M | -3.21M | -1.80M | -1.04M | -3.10M | -2.80M | -3.88M | -4.81M | -5.01M | -2.41M |
Earnings per share | ||||||||||
Basic EPS | -0.02 | -0.02 | -0.01 | -0.01 | -0.03 | -0.03 | -0.05 | -0.1 | -0.15 | -0.09 |
Diluted EPS | -0.02 | -0.02 | -0.01 | -0.01 | -0.03 | -0.03 | -0.05 | -0.1 | -0.15 | -0.09 |